| Company/Division name | Copan Diagnostics, Inc. |
| Parent company | COPAN Group |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 250 |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 10 |
| Country(ies) from which reshored: | Italy |
| City reshored to: | Carlsbad |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | SARS-CoV-2 sample collection and transport kits |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Lead time/Time to market, Skilled workforce availability/training, Other, Covid-19, import replacement |
